Literature DB >> 29855973

Sleep Disturbance and Total Sleep Time in Persons Living with HIV: A Cross-Sectional Study.

Brice Faraut1,2, Alexandre Malmartel3,4, Jade Ghosn5, Martin Duracinsky6, Damien Leger1,2, Sophie Grabar7,8, Jean-Paul Viard5.   

Abstract

Short and long sleep durations have been associated with inflammation and chronic diseases. To study the association between sleep duration/quality and HIV disease severity, a cross-sectional study was conducted in patients living with HIV (PLWHs) using self-administered questionnaires assessing total sleep time, insomnia (ICSD-3 criteria), and poor sleep quality (PSQI > 5). Multivariable logistic regression identified the factors associated with sleep disorders and with HIV features. 640 Parisian ambulatory PLWHs were included. The prevalence of insomnia was 50 and 68% of patients had a PSQI > 5. Patients with CD4 count < 500 cells/mm3 were more likely to be long sleepers (> 8 h/day) (OR 1.49; 95% CI [1.10-1.99]: p < 0.01), and less likely to be short sleepers (< 6 h/day) (OR 0.69; 95% CI[0.50-0.96]; p = 0.04) or to experience insomnia (OR 0.59; 95% CI[0.40-0.86]; p < 0.01). HIV features were not associated with a PSQI > 5. Thus, insomnia and impaired sleep quality were highly prevalent in well-controlled PLWHs and the severity of HIV infection was associated with long sleep times.

Entities:  

Keywords:  HIV infection; Insomnia; Sleep disorder; Total sleep time

Mesh:

Year:  2018        PMID: 29855973     DOI: 10.1007/s10461-018-2179-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  8 in total

1.  Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice.

Authors:  Benjamin J Bell; Kristen R Hollinger; Pragney Deme; Shinji Sakamoto; Yuto Hasegawa; David Volsky; Atsushi Kamiya; Norman Haughey; Xiaolei Zhu; Barbara S Slusher
Journal:  Brain Behav Immun Health       Date:  2022-06-09

2.  A supervised exercise intervention fails to improve subjective and objective sleep measures among older adults with and without HIV.

Authors:  Brian Hixon; Helen J Burgess; Melissa P Wilson; Samantha MaWhinney; Catherine M Jankowski; Kristine M Erlandson
Journal:  HIV Res Clin Pract       Date:  2020-10-29

3.  Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study.

Authors:  Ken M Kunisaki; Davide De Francesco; Caroline A Sabin; Alan Winston; Patrick W G Mallon; Jane Anderson; Emmanouil Bagkeris; Marta Boffito; Nicki Doyle; Lewis Haddow; Frank A Post; Memory Sachikonye; Jaime Vera; Wajahat Khalil; Susan Redline
Journal:  Open Forum Infect Dis       Date:  2020-11-18       Impact factor: 4.423

4.  Sleep Disturbance in the Context of HIV: A Concept Analysis.

Authors:  Hening Pujasari; Min-Huey Chung
Journal:  SAGE Open Nurs       Date:  2022-04-20

5.  Sleep, Prospective Memory, and Immune Status among People Living with HIV.

Authors:  Brice Faraut; Lorenzo Tonetti; Alexandre Malmartel; Sophie Grabar; Jade Ghosn; Jean-Paul Viard; Vincenzo Natale; Damien Léger
Journal:  Int J Environ Res Public Health       Date:  2021-01-08       Impact factor: 3.390

6.  Identifying subtypes of HIV/AIDS-related symptoms in China using latent profile analysis and symptom networks.

Authors:  Zhongfang Yang; Zheng Zhu; Huan Wen; Shuyu Han; Lin Zhang; Yanfen Fu; Yan Hu; Bei Wu
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

7.  Application of the Chinese Version of the Pittsburgh Sleep Quality Index in People Living With HIV: Preliminary Reliability and Validity.

Authors:  Dong-Qin Yan; Yun-Xiang Huang; Xi Chen; Min Wang; Jie Li; Dan Luo
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

8.  Ethical considerations for HIV cure-related research at the end of life.

Authors:  Karine Dubé; Sara Gianella; Susan Concha-Garcia; Susan J Little; Andy Kaytes; Jeff Taylor; Kushagra Mathur; Sogol Javadi; Anshula Nathan; Hursch Patel; Stuart Luter; Sean Philpott-Jones; Brandon Brown; Davey Smith
Journal:  BMC Med Ethics       Date:  2018-10-20       Impact factor: 2.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.